In Vitro Study of Cytostatic Activity of Baicalin, Baicalein, and Chlorophyllipt on HeLa-v Cell Line.
Chlorophyllipt
Taxacad
baicalein
baicalin
cytostatic activity
Journal
Bulletin of experimental biology and medicine
ISSN: 1573-8221
Titre abrégé: Bull Exp Biol Med
Pays: United States
ID NLM: 0372557
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
22
09
2022
medline:
22
5
2023
pubmed:
12
5
2023
entrez:
11
5
2023
Statut:
ppublish
Résumé
Cytostatic activity of baicalin, baicalein, and neogalenical drug Chlorophyllipt was studied in vitro on HeLa-v cells. Standard samples of Eucalimin, baicalin, and baicalein, as well as Chlorophyllipt and paclitaxel (reference drug Taxacad) were used. The cell deaths were determined by MTT assay in a Multiskan FC microplate reader with incubator. The effective inhibition concentration (IC
Identifiants
pubmed: 37170019
doi: 10.1007/s10517-023-05782-6
pii: 10.1007/s10517-023-05782-6
doi:
Substances chimiques
baicalin
347Q89U4M5
baicalein
49QAH60606
Cytostatic Agents
0
chlorophyllypt
12750-97-9
Flavonoids
0
Flavanones
0
Paclitaxel
P88XT4IS4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
738-740Informations de copyright
© 2023. Springer Science+Business Media, LLC, part of Springer Nature.
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
doi: 10.3322/caac.21492
pubmed: 30207593
The State Of Cancer Care in Russia in 2021. Kaprin AD, Starinsky VV, Shakhzadova AO, eds. Moscow, 2022. Russian.
Malhotra V, Perry MC. Classical chemotherapy: mechanisms, toxicities and the therapeutic window. Cancer Biol. Ther. 2003;2(4, Suppl. 1):S2-S4.
Zhang RX, Wong HL, Xue HY, Eoh JY, Wu XY. Nanomedicine of synergistic drug combinations for cancer therapy — Strategies and perspectives. J Control Release. 2016;240:489-503. https://doi.org/10.1016/j.jconrel.2016.06.012
doi: 10.1016/j.jconrel.2016.06.012
pubmed: 27287891
pmcid: 5064882
Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O. Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front. Pharmacol. 2020;10:1614. https://doi.org/10.3389/fphar.2019.01614
doi: 10.3389/fphar.2019.01614
pubmed: 32116665
pmcid: 7025531
Pezzani R, Salehi B, Vitalini S, Iriti M, Zuñiga FA, Sharifi-Rad J, Martorell M, Martins N. Synergistic effects of plant derivatives and conventional chemotherapeutic agents: an update on the cancer perspective. Medicina (Kaunas). 2019;55(4):110. https://doi.org/10.3390/medicina55040110
doi: 10.3390/medicina55040110
pubmed: 30999703
pmcid: 6524059
Liu H, Dong Y, Gao Y, Du Z, Wang Y, Cheng P, Chen A, Huang H. The fascinating effects of baicalein on cancer: a review. Int. J. Mol. Sci. 2016;17(10):1681. https://doi.org/10.3390/ijms17101681
doi: 10.3390/ijms17101681
pubmed: 27735841
pmcid: 5085714
Lu C, Wang H, Chen S, Yang R, Li H, Zhang G. Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway. J. Cell Mol. Med. 2018;22(4):2478-2487. https://doi.org/10.1111/jcmm.13556
doi: 10.1111/jcmm.13556
pubmed: 29392841
pmcid: 5867147
Peng LY, He J, Xu G, Wu XD, Dong LB, Gao X, Cheng X, Su J, Li Y, Zhao QS. Euglobal-IIIa, a novel acylphloroglucinol-sesquiterpene derivative from Eucalyptus robusta: absolute structure and cytotoxicity. Nat. Prod. Bioprospect. 2011;1:101-103. https://doi.org/10.1007/s13659-011-0021-9
doi: 10.1007/s13659-011-0021-9
pmcid: 4131649
Soliman FM, Fathy MM, Salama MM, Al-Abd AM, Saber FR, El-Halawany AM. Cytotoxic activity of acyl phloroglucinols isolated from the leaves of Eucalyptus cinerea F. Muell. ex Benth. cultivated in Egypt. Sci. Rep. 2014;4:5410. https://doi.org/10.1038/srep05410
Takasaki M, Konoshima T, Etoh H, Pal Singh I, Tokuda H, Nishino H. Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis. Cancer Lett. 2000;155(1):61-65. https://doi.org/10.1016/s0304-3835(00)00406-7
doi: 10.1016/s0304-3835(00)00406-7
pubmed: 10814880
Takasaki M, Konoshima T, Kozuka M, Tokuda H. Anti-tumor-promoting activities of euglobals from Eucalyptus plants. Biol. Pharm. Bull. 1995;18(3):435-438. https://doi.org/10.1248/bpb.18.435
doi: 10.1248/bpb.18.435
pubmed: 7550098
Boyko N, Pisarev D, Zhilyakova E, Pravlotskaya A, Novikov O, Makarevich N, Kuznietsova V, Sushchuk N. Study and modeling of the distribution process of some phenolic compounds between the solid and liquid phases. J. Adv. Pharm. Technol. Res. 2019;10(2):56-62. https://doi.org/10.4103/japtr.JAPTR_392_18
doi: 10.4103/japtr.JAPTR_392_18
pubmed: 31041183
pmcid: 6474166
Boyko NN, Zhilyakova ET, Pisarev DI, Novikov OO, Mizina PG, Saybel OL, Sidelnikova MK. A new method for selective extraction of euglobals with monoterpenoid structure from eucalyptus viminalis leaves. Voprosy Biol. Med. Farmatsevt. Khimii. 2019;22(12):12-22. Russian. https://doi.org/10.29296/25877313-2019-12-02
Boyko NN, Pisarev DI, Zhilyakova ET, Novikov OO. The comparative analysis of the biologically active substances in tinctura Eucalypti and Chlorophyllipt medicines. Voprosy Biol. Med. Farmatsevt. Khimii. 2018;21(11):16-23. Russian. https://doi.org/10.29296/25877313-2018-11-02